Applied Clinical Trials-03-06-2006

March 06, 2006

entimICER DARE dramatically improves how pharmaceutical companies can manage, analyze, and report on clinical data.

March 06, 2006

Jean-Francois Dehecq, sanofi-aventis, France, noted that innovation is founded in strong science and research, is critical for success and competitiveness, and contributes to the health of patients and wealth of society.

March 06, 2006

Opening of new frontiers in the diagnosis of allergy to more than 20 different metals and a large number of allergens from a single blood sample

March 06, 2006

Oracle Introduces Oracle® Clinical Data Repository to Help Life Sciences Organizations Accelerate Decision Making, Reduce Risk and Streamline Compliance - Pharmaceutical Manufacturer Boehringer Ingelheim Begins Implementation

March 06, 2006

Cognitive Drug Research (CDR) has formed an alliance with Pharma Services Network to further their business in North America.

March 06, 2006

ACT had a chance to catch up with Dr. Rose, MD, MS, Head Pediatrics, F. Hoffmann-La Roche Ltd, Pharmaceutical Division.

March 06, 2006

Phase Forward Senior Professional Barry Burnstead Honored with Membership Lifetime Award

March 06, 2006

Chief Medical Officer Ed Ikeguchi to Present on UK’s Nationwide EDC Deployment; Senior Director Anne Zielinski to Highlight Data Integration Techniques

March 06, 2006

Take a pictorial tour of Paris with the editors of Applied Clinical Trials

March 06, 2006

Program Co-Chairs Iman Barilero, Johnson & Johnson PRD, and Marie Dray, International Regulatory Affairs Group USA, opened the first plenary session with introductions, sharing their vision of what the 18th Annual DIA EuroMeeting is all about: continuing themes throughout the meeting, including pediatrics, advanced therapies, technology platform, pharmacovigilance, risk management planning, and the involvement of patient groups.

March 06, 2006

Dr. Cynthia Kirk has joined PRA International as Vice President, Global Regulatory Affairs.

March 06, 2006

The first keynote speaker Georgette Lalis, Head of DG Enterprise and Industry for the European Commission, began her presentation "The Decline of Pharmaceutical Innovation in Europe" by acknowledging, "Innovation is the life blood of the pharmaceutical industry." She added that regulators must be equally innovative, playing a key role in the growth of R&D development in Europe, noting that Europe is facing massive health threats and the health system is under distress.

March 06, 2006

2,500+ International Professionals from Industry, Academia, and Regulatory Agencies Convene in Paris: 17 Meeting Tracks Including 400+ Speakers, 170+ Exhibits and 14 Tutorials

March 06, 2006

ClinPhone will be exhibiting its complete range of clinical trial technology services at the 18th Annual DIA Euro Meeting.

March 06, 2006

Find Out at the DIA Annual EuroMeeting

March 06, 2006

The Latest Headlines from Europe

March 06, 2005

Welcoming attendees to the EuroMeeting were Brigitte Franke-Bray, DIA Director, European branch office, Switzerland; Theresa Kane Musser, DIA President, Rigel Pharmaceuticals, USA; Jean Marimbert, Director General, Afssaps, France; and David Maola, DIA Executive Director. Opening remarks were followed by brief speeches from the two candidates running for DIA President: Ron Fitzmartin, Vice President of Global Technical Services, Daiichi Medical Research, USA, and Dr. Jeffery Sherman, Executive Vice President, NeoPharm, USA.